Karel Van Damme

TIM3+<i> TRBV11-2</i> T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Levi Hoste, Lisa Roels, Leslie Naesens et al. · The Journal of Experimental Medicine · 2021 · 86 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

Karel Van Damme, Simon J. Tavernier, Nele Van Roy et al. · Frontiers in Immunology · 2020 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

Cédric Bosteels, Karel Van Damme, Elisabeth De Leeuw et al. · Cell Reports Medicine · 2022 · 43 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Ethical Aspects of Human Placental Perfusion: Interview of the Mothers Donating Placenta

Arja Halkoaho, Anna‐Maija Pietilä, Birgit Dumez et al. · Placenta · 2010 · 31 citations

Medicine, Maternal Health, Obstetrics +9

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

Elisabeth De Leeuw, Karel Van Damme, Jozefien Declercq et al. · Respiratory Research · 2022 · 22 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16